Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening
Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening
Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening
original article
A bs t r ac t
Background
From the Departments of Pediatric Car Epidemiologic studies of the prevalence of rheumatic heart disease have used clinical
diology (E.M., D.S.) and Pediatric Ra screening with echocardiographic confirmation of suspected cases. We hypothesized
diology (P.O.), Hôpital Necker–Enfants
Malades, Paris; the University Paris Des that echocardiographic screening of all surveyed children would show a significantly
cartes, Georges Pompidou European Hos higher prevalence of rheumatic heart disease.
pital, Paris (E.M., X.J.); the Maputo Heart
Institute, Maputo, Mozambique (E.M.,
B.F., A.O.M., D.J.); the Phnom Penh Heart
Methods
Center, Phnom Penh, Cambodia (P.O.); Randomly selected schoolchildren from 6 through 17 years of age in Cambodia and
the Department of Medicine, Sydney Uni Mozambique were screened for rheumatic heart disease according to standard clin-
versity, Sydney (D.S.C.); the National Insti
tute for Public Health Surveillance, Saint ical and echocardiographic criteria.
Maurice, France (C.P.); and INSERM, Unité
780 Avenir, Cardiovascular Epidemiology, Results
Villejuif, France (S.J., X.J.). Address reprint
requests to Dr. Marijon at the Hôpital Clinical examination detected rheumatic heart disease that was confirmed by echo-
Europeén Georges Pompidou, Service de cardiography in 8 of 3677 children in Cambodia and 5 of 2170 children in Mozam-
Cardiologie 2, 20 rue Leblanc, 75908 Paris bique; the corresponding prevalence rates and 95% confidence intervals (CIs) were
CEDEX 15, France, or at eloi_marijon@
yahoo.fr. 2.2 cases per 1000 (95% CI, 0.7 to 3.7) for Cambodia and 2.3 cases per 1000 (95% CI,
0.3 to 4.3) for Mozambique. In contrast, echocardiographic screening detected 79
N Engl J Med 2007;357:470-6. cases of rheumatic heart disease in Cambodia and 66 cases in Mozambique, corre-
Copyright © 2007 Massachusetts Medical Society.
sponding to prevalence rates of 21.5 cases per 1000 (95% CI, 16.8 to 26.2) and 30.4
cases per 1000 (95% CI, 23.2 to 37.6), respectively. The mitral valve was involved in
the great majority of cases (87.3% in Cambodia and 98.4% in Mozambique).
Conclusions
Systematic screening with echocardiography, as compared with clinical screening, re-
veals a much higher prevalence of rheumatic heart disease (approximately 10 times
as great). Since rheumatic heart disease frequently has devastating clinical consequenc-
es and secondary prevention may be effective after accurate identification of early
cases, these results have important public health implications.
I
n poor and developing nations, rheu- tive of two regions of the developing world where
matic heart disease remains a major cause of previous surveys have documented an apparently
morbidity and premature death and imposes high prevalence of rheumatic heart disease in
a substantial burden on health care systems with school-age children2 and because local investiga-
limited budgets.1,2 Nevertheless, primary and sec-tors and authorities were willing and able to par-
ondary prevention efforts may be highly effective.1,3
ticipate in the studies. The two studies were carried
Secondary prevention relies on accurate case detec-
out after prospective planning by a central group
tion for the appropriate use of prophylactic antibi-
of investigators, which included establishing pro-
otics and regular medical surveillance. Exact prev-
tocols for prospectively defined clinical and echo-
alence data are also highly desirable to facilitate
cardiographic criteria for the diagnosis of rheumat-
health care planning. ic valvular abnormalities.
Almost all population-based epidemiologic sur- The first study was carried out in Cambodia
veys have relied on careful clinical examination of
in 2001 and 2002 after approval by the Ministry
school-age children, with confirmation of clini- of Health. The investigators approached the direc-
cally suspected cases by echocardiography. Such tors of randomly selected schools in the capital of
surveys show current prevalence rates of rheu- Phnom Penh, and all agreed to participate. All
matic heart disease of approximately 1 to 5 cases children in each school were invited to participate;
per 1000 among school-age children in developing those children whose parents or guardians gave
countries, with the highest rates in sub-Saharan oral informed consent were brought to the Phnom
Africa.2 Penh Heart Center, where they underwent com-
Cardiac ultrasonography is known to be more prehensive clinical and echocardiographic exami-
sensitive than auscultation for the detection of nation (with a Philips Sonos 4500 4–7 MHz trans-
pathologic valve disease,4 and the recent availabil-
ducer) for signs of rheumatic heart disease. Images
ity of high-quality portable ultrasound equipment were recorded on super-VHS videotape for later
makes it possible to screen large numbers of chil-review by an independent physician who was ex-
dren at schools in developing nations. Further- perienced in diagnosing rheumatic heart disease
more, the 2004 World Health Organization Expert and was not aware of the clinical findings. The
Consultation Report states that echocardiograph- results of this study appeared to confirm our hy-
ically diagnosed, clinically silent rheumatic valve
pothesis that a much higher prevalence of rheu-
involvement should be managed as rheumatic matic heart disease would be found with echocar-
heart disease until proved otherwise.3 We there- diographic screening. We then decided to repeat
fore hypothesized that comprehensive screening, the study with more rigorous randomization pro-
including echocardiography in all children, might cedures for subject selection and with confirma-
reveal a higher prevalence of cases than clinical tion of echocardiographic findings by multiple in
examination with echocardiographic confirmation dependent observers.
of clinically suspected cases only. We conducted a survey in Mozambique from
We performed two large, population-based May through October 2005 after approval of the
studies of school-age children, one in Southeast survey by the ethics committee of the Ministry of
Asia (Cambodia) and one in sub-Saharan Africa Health and the Education Ministry. A total of 2170
(Mozambique), to assess the feasibility of echocar-
pupils from six public primary schools were ran-
diographic screening and to ascertain whether thisdomly selected from among the 1,140,000 chil-
method would yield a more realistic estimate of dren 6 through 17 years of age living in the capi-
the prevalence of rheumatic heart disease than that
tal city of Maputo. The overall sample was equally
obtained by screening with the use of predomi- distributed among seven class levels, with 310
nantly clinical criteria. subjects per class level, in order to ensure an even
age distribution. Two thirds of the children (1440)
Me thods were from suburban schools and one third (730)
were from urban schools. For each class level,
Setting and survey methods classrooms were selected by means of a systematic
Our study was conducted in Cambodia and Mo- randomization procedure with Epi Info software
zambique, because these countries are representa- (version 3.3.2). In each selected classroom, all chil-
dren for whom written informed consent could be least two of the following three morphologic ab-
obtained from a parent or guardian (91.6% of chil- normalities of the regurgitant valve: restricted
dren) were included in the study. leaflet mobility, focal or generalized valvular thick-
For each child, any history of acute rheumatic ening, and abnormal subvalvular thickening. For
fever was noted. The participating children then a definite diagnosis of rheumatic heart disease,
underwent a detailed clinical and echocardio- these features had to be identified concordantly by
graphic examination (with a SonoSite 4.2 MHz each of the echocardiographers, all of whom were
transducer) at the school. Absentees were noted experienced in the diagnosis and treatment of
and revisits were made to examine all of them. rheumatic heart disease.
All children in whom cardiac abnormalities were
noted with the portable ultrasound system under- Statistical Analysis
went repeated scanning at the Maputo Heart Insti- Each study enrolled more than 2000 children and
tute (with a Philips Sonos 4500 4–7 MHz trans- had more than 90% power at the 0.01 significance
ducer). These images were recorded on super-VHS level to test the hypothesis that echocardiograph-
videotape for later analysis by three independent ic screening would reveal twice as many cases of
physicians experienced in diagnosing rheumatic rheumatic heart disease as would be expected on
heart disease. the basis of published prevalence data from clin-
In both studies, children with a diagnosis of ical screening studies (5 cases per 1000 children).2
acute rheumatic fever according to the revised Our sample-size calculation was based on the re-
Jones criteria were treated with salicylates and an- sults of previous studies of the clinical prevalence
tibiotic agents.5 Each child in whom rheumatic of rheumatic heart disease; since the prevalence ob-
valve lesions were detected by echocardiography served in our studies was higher than expected,
was followed up with medical surveillance every our sample sizes clearly were overestimated.
6 months, including clinical and echocardiograph- All data were analyzed at INSERM, Unit 780
ic review, initiation of antibiotic prophylaxis in Avenir, Cardiovascular Epidemiology, Villejuif,
cases of lesions considered to be significant ac- France, with SAS software (version 8.2). Descrip-
cording to World Health Organization criteria, and tive data are presented as means ±SD; sample
surgical treatment where clinically indicated. means were compared with an independent-sam-
ples Student’s t-test. A two-sided P value of less
Clinical and echocardiographic definitions than 0.05 was considered to indicate statistical
Clinical examination was performed by physicians significance. We calculated the fraction of children
experienced in the diagnosis of rheumatic heart whose findings were normal by clinical criteria
disease. Careful cardiac auscultation was per- and abnormal by echocardiographic criteria. In
formed with the patient in the supine and left lat- addition, the rate of detection by echocardiograph-
eral decubitus positions. Children in whom an or- ic screening was calculated by means of the total
ganic murmur was detected clinically and the probability formula as follows: rate of detection =
presence of rheumatic heart disease was confirmed p1 + (1 − p1) × p2, where p1 is the probability of
echocardiographically were classified as having an abnormal result by clinical screening and p2 is
clinically detected rheumatic heart disease. the probability of an abnormal result by echocar-
The echocardiographic criteria were agreed on diographic screening after a normal result by
by all observers in both the Cambodian and the clinical screening.
Mozambique studies before the ultrasound scans
were read by echocardiographers who were un- R e sult s
aware of the clinical findings. Only left-sided
valves were examined for features of rheumatic Cambodia
heart disease; mild tricuspid regurgitation and Of the 3677 children examined in Cambodia, 52.0%
pulmonary regurgitation were frequently noted but were male, and the mean age was 11.7±2.5 years
were not regarded as indicating rheumatic heart (Table 1). Clinical evidence of rheumatic heart dis-
disease. Rheumatic heart disease was defined by ease confirmed by echocardiography was found in
the presence of any definite evidence of mitral- or 8 children, corresponding to a prevalence of 2.2
aortic-valve regurgitation seen in two planes by cases per 1000 children (95% confidence interval
Doppler echocardiography, accompanied by at [CI], 0.7 to 3.7). Five of these eight children ful-
such cases. Furthermore, the latest report on rheu- from charitable organizations. Our results might
matic heart disease from the World Health Orga- encourage a strategy of echocardiography-based
nization states that in areas where rheumatic heart screening programs for rheumatic heart disease,
disease is endemic, echocardiography may be used involving education and both primary and second-
to diagnose “silent but significant rheumatic car- ary prophylaxis, and based on accurate assessment
ditis of insidious onset” and recommends that of the prevalence of rheumatic heart disease.14
such cases be managed as rheumatic heart disease In summary, we have documented a much
until proved otherwise.3 Although echocardio- higher prevalence of rheumatic valvular abnor-
graphic criteria are still not included in the Jones malities in school-age children than was previ-
criteria, this recommendation may represent a new ously suspected in both Southeast Asia and
step toward acknowledgment of subclinical le- sub-Saharan Africa. Comprehensive echocardio-
sions. graphic screening identified approximately 10
Even though portable echocardiographic equip- times as many children with rheumatic heart dis-
ment is now highly developed and accurate, echo- ease as were identified by the traditional strategy
cardiographic screening may not be a practicable of clinical screening with echocardiographic con-
local solution for case identification under the cur- firmation. Because rheumatic heart disease re-
rent financial constraints on provision of diagnos- mains a major cause of morbidity and mortality in
tic services in developing nations. Nevertheless, developing nations, these data have potentially
the observation that approximately 90% of cases important implications for case finding, delivery
of rheumatic heart disease in our study were clini- of effective primary and secondary prevention, and
cally silent, occurring in asymptomatic children adequate planning of health services.
without audible murmurs, suggests that echocar- Supported by grants from La Chaîne de l’Espoir, Paris, and
diographic screening would be a desirable goal to Cadeia da Esperança, Coimbra, Portugal.
No potential conflict of interest relevant to this article was
optimize case identification and targeted (second- reported.
ary) prevention measures. Funds for the purchase We thank the participating staff at the Phnom Penh Heart
of the ultrasound equipment — the major expense Center and the Maputo Heart Institute for their contributions to
the study, and P. Ducimetière, J.P. Empana, and A. Kane at
of an ultrasound-based screening program for INSERM, Unité 780 Avenir, Hôpital Paul Brousse, Assistance
rheumatic heart disease — might be obtainable Publique–Hôpitaux de Paris, for their technical assistance.
Appendix
The principal investigators in this study were P. Ou in Cambodia and E. Marijon and B. Ferreira in Mozambique.
References
1. Carapetis JR, McDonald M, Wilson NJ. 6. Carapetis JR, Currie BJ, Mathews JD. 11. Figueroa FE, Fernandez MS, Valdes P,
Acute rheumatic fever. Lancet 2005;366: Cumulative incidence of rheumatic fever et al. Prospective comparison of clinical
155-68. in an endemic region: a guide to the sus- and echocardiographic diagnosis of rheu-
2. Carapetis JR, Steer AC, Mulholland ceptibility of the population? Epidemiol matic carditis: long term follow up of pa-
EK, Weber M. The global burden of group Infect 2000;124:239-44. tients with subclinical disease. Heart 2001;
A streptococcal diseases. Lancet Infect Dis 7. Meira ZM, Goulart EM, Colosimo EA, 85:407-10.
2005;5:685-94. Mota CC. Long term follow up of rheu- 12. Minich LL, Tani LY, Pagotto LT, Shaddy
3. Rheumatic fever and rheumatic heart matic fever and predictors of severe RE, Veasy LG. Doppler echocardiography
disease: report of a WHO Expert Consul- rheumatic valvar disease in Brazilian chil- distinguishes between physiologic and
tation, Geneva, 29 October–1 November dren and adolescents. Heart 2005;91:1019- pathologic “silent” mitral regurgitation in
2001. Geneva: World Health Organiza- 22. patients with rheumatic fever. Clin Cardiol
tion, 2004. 8. Anabwani GM, Bonhoeffer P. Preva- 1997;20:924-6.
4. Veasy LG. Time to take soundings in lence of heart disease in school children 13. Wilson NJ, Neutze JM. Echocardio-
acute rheumatic fever. Lancet 2001;357: in rural Kenya using colour-flow echocar- graphic diagnosis of subclinical carditis in
1994-5. diography. East Afr Med J 1996;73:215-7. acute rheumatic fever. Int J Cardiol 1995;
5. Special Writing Group of the Commit- 9. Narula J, Kaplan EL. Echocardiograph- 50:1-6.
tee on Rheumatic Fever, Endocarditis, and ic diagnosis of rheumatic fever. Lancet 14. McDonald M, Brown A, Noonan S,
Kawasaki Disease of the Council on Car- 2001;358:2000. Carapetis JR. Preventing recurrent rheu-
diovascular Disease in the Young of the 10. Vasan RS, Shrivastava S, Vijayakumar matic fever: the role of register based pro-
American Heart Association. Guidelines M, Narang R, Lister BC, Narula J. Echo- grammes. Heart 2005;91:1131-3.
for the diagnosis of rheumatic fever: Jones cardiographic evaluation of patients with Copyright © 2007 Massachusetts Medical Society.
Criteria, 1992 update. JAMA 1992;268: acute rheumatic fever and rheumatic car-
2069-73. [Erratum, JAMA 1993;269:476.] ditis. Circulation 1996;94:73-82.